wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36511158-E2E64355-37C9-43EB-A0D8-CB52F396AD46
Q36511158-E2E64355-37C9-43EB-A0D8-CB52F396AD46
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36511158-E2E64355-37C9-43EB-A0D8-CB52F396AD46
Phase I and clinical pharmacology study of bevacizumab, sorafenib, and low-dose cyclophosphamide in children and young adults with refractory/recurrent solid tumors.
P2860
Q36511158-E2E64355-37C9-43EB-A0D8-CB52F396AD46
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36511158-E2E64355-37C9-43EB-A0D8-CB52F396AD46
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7ad31d03a98e6719e996c001fd01c78b98c946c2
P2860
A phase 1 trial and pharmacokinetic study of cediranib, an orally bioavailable pan-vascular endothelial growth factor receptor inhibitor, in children and adolescents with refractory solid tumors.